MONMOUTH JUNCTION, NJ–(Marketwired – April 28, 2014) – DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based tests for detection and monitoring of neurodegenerative diseases and cancer, announced today that the company’s CEO, Dr. Kira Sheinerman, will participate in the 10th Biomarkers & Diagnostics World Congress in Philadelphia, PA and will present clinical data and analysis of circulating brain-enriched microRNAs for detection and differentiation of Mild Cognitive Impairment, Alzheimer’s and Parkinson’s diseases.